ACUTUS MEDICAL INC (AFIB) Stock Overview
USA - NASDAQ:AFIB - US0051111096 - Common Stock
AFIB Key Statistics, Chart & Performance
The current stock price of AFIB is 0.09 USD. In the past month the price decreased by -45.05%. In the past year, price decreased by -89.69%.
AFIB Latest News, Press Relases and Analysis
AFIB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.94 | 216.57B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.44 | 192.72B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34 | 148.62B | ||
| SYK | STRYKER CORP | 28.76 | 141.30B | ||
| MDT | MEDTRONIC PLC | 16.59 | 117.66B | ||
| BDX | BECTON DICKINSON AND CO | 12.72 | 52.03B | ||
| IDXX | IDEXX LABORATORIES INC | 52.26 | 50.21B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.18 | 48.55B | ||
| RMD | RESMED INC | 26.56 | 37.01B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.61 | 35.33B | ||
| DXCM | DEXCOM INC | 40.11 | 26.74B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.53 | 26.58B |
Related stock screener links
About AFIB
Company Profile
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 225 full-time employees. The company went IPO on 2020-08-06. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The firm's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.
Company Info
ACUTUS MEDICAL INC
2210 Faraday Ave Ste 100
Carlsbad CALIFORNIA 92008 US
CEO: Vince Burgess
Employees: 225
Phone: 14422326144
ACUTUS MEDICAL INC / AFIB FAQ
What does AFIB do?
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 225 full-time employees. The company went IPO on 2020-08-06. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The firm's product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.
What is the stock price of ACUTUS MEDICAL INC today?
The current stock price of AFIB is 0.09 USD. The price decreased by -26.83% in the last trading session.
Does ACUTUS MEDICAL INC pay dividends?
AFIB does not pay a dividend.
What is the ChartMill technical and fundamental rating of AFIB stock?
AFIB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for ACUTUS MEDICAL INC?
ACUTUS MEDICAL INC (AFIB) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Who owns ACUTUS MEDICAL INC?
You can find the ownership structure of ACUTUS MEDICAL INC (AFIB) on the Ownership tab.
AFIB Technical Analysis
AFIB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AFIB. Both the profitability and financial health of AFIB have multiple concerns.
AFIB Financial Highlights
Over the last trailing twelve months AFIB reported a non-GAAP Earnings per Share(EPS) of -2.69. The EPS increased by 34.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -111.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AFIB Forecast & Estimates
6 analysts have analysed AFIB and the average price target is 1.53 USD. This implies a price increase of 1600% is expected in the next year compared to the current price of 0.09.
For the next year, analysts expect an EPS growth of 12.16% and a revenue growth 31.1% for AFIB